| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |